Ginkgo Bioworks Holdings, Inc. (DNA)
8.71
+0.02
(+0.23%)
USD |
NYSE |
May 27, 16:00
8.75
+0.04
(+0.46%)
After-Hours: 20:00
Ginkgo Bioworks Holdings EPS Diluted (Quarterly) : -1.386 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.074 |
| Inotiv, Inc. | -0.9369 |
| Bio-Rad Laboratories, Inc. | -19.55 |
| Bruker Corp. | 0.0229 |
| Azenta, Inc. | -3.491 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -76.06M |
| Revenue (Quarterly) | 19.47M |
| Total Expenses (Quarterly) | 95.53M |
| Enterprise Value | 599.34M |
| Gross Profit Margin (Quarterly) | 18.37% |
| Profit Margin (Quarterly) | -390.6% |
| Earnings Yield | -61.92% |
| Normalized Earnings Yield | -62.17 |